Farzad Shahabi, Samuel L. Battalio, Angela Fidler Pfammatter, Donald Hedeker, Bonnie Spring, Nabil Alshurafa
{"title":"利用治疗早期体重变化特征预测减肥成功的机器学习模型","authors":"Farzad Shahabi, Samuel L. Battalio, Angela Fidler Pfammatter, Donald Hedeker, Bonnie Spring, Nabil Alshurafa","doi":"10.1038/s41746-024-01299-y","DOIUrl":null,"url":null,"abstract":"Stepped-care obesity treatments aim to improve efficiency by early identification of non-responders and adjusting interventions but lack validated models. We trained a random forest classifier to improve the predictive utility of a clinical decision rule (>0.5 lb weight loss/week) that identifies non-responders in the first 2 weeks of a stepped-care weight loss trial (SMART). From 2009 to 2021, 1058 individuals with obesity participated in three studies: SMART, Opt-IN, and ENGAGED. The model was trained on 80% of the SMART data (224 participants), and its in-distribution generalizability was tested on the remaining 20% (remaining 57 participants). The out-of-distribution generalizability was tested on the ENGAGED and Opt-IN studies (472 participants). The model predicted weight loss at month 6 with an 84.5% AUROC and an 86.3% AUPRC. SHAP identified predictive features: weight loss at week 2, ranges/means and ranges of weight loss, slope, and age. The SMART-trained model showed generalizable performance with no substantial difference across studies.","PeriodicalId":19349,"journal":{"name":"NPJ Digital Medicine","volume":" ","pages":"1-10"},"PeriodicalIF":12.4000,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s41746-024-01299-y.pdf","citationCount":"0","resultStr":"{\"title\":\"A machine-learned model for predicting weight loss success using weight change features early in treatment\",\"authors\":\"Farzad Shahabi, Samuel L. Battalio, Angela Fidler Pfammatter, Donald Hedeker, Bonnie Spring, Nabil Alshurafa\",\"doi\":\"10.1038/s41746-024-01299-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Stepped-care obesity treatments aim to improve efficiency by early identification of non-responders and adjusting interventions but lack validated models. We trained a random forest classifier to improve the predictive utility of a clinical decision rule (>0.5 lb weight loss/week) that identifies non-responders in the first 2 weeks of a stepped-care weight loss trial (SMART). From 2009 to 2021, 1058 individuals with obesity participated in three studies: SMART, Opt-IN, and ENGAGED. The model was trained on 80% of the SMART data (224 participants), and its in-distribution generalizability was tested on the remaining 20% (remaining 57 participants). The out-of-distribution generalizability was tested on the ENGAGED and Opt-IN studies (472 participants). The model predicted weight loss at month 6 with an 84.5% AUROC and an 86.3% AUPRC. SHAP identified predictive features: weight loss at week 2, ranges/means and ranges of weight loss, slope, and age. The SMART-trained model showed generalizable performance with no substantial difference across studies.\",\"PeriodicalId\":19349,\"journal\":{\"name\":\"NPJ Digital Medicine\",\"volume\":\" \",\"pages\":\"1-10\"},\"PeriodicalIF\":12.4000,\"publicationDate\":\"2024-11-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.nature.com/articles/s41746-024-01299-y.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Digital Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/s41746-024-01299-y\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Digital Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/s41746-024-01299-y","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
A machine-learned model for predicting weight loss success using weight change features early in treatment
Stepped-care obesity treatments aim to improve efficiency by early identification of non-responders and adjusting interventions but lack validated models. We trained a random forest classifier to improve the predictive utility of a clinical decision rule (>0.5 lb weight loss/week) that identifies non-responders in the first 2 weeks of a stepped-care weight loss trial (SMART). From 2009 to 2021, 1058 individuals with obesity participated in three studies: SMART, Opt-IN, and ENGAGED. The model was trained on 80% of the SMART data (224 participants), and its in-distribution generalizability was tested on the remaining 20% (remaining 57 participants). The out-of-distribution generalizability was tested on the ENGAGED and Opt-IN studies (472 participants). The model predicted weight loss at month 6 with an 84.5% AUROC and an 86.3% AUPRC. SHAP identified predictive features: weight loss at week 2, ranges/means and ranges of weight loss, slope, and age. The SMART-trained model showed generalizable performance with no substantial difference across studies.
期刊介绍:
npj Digital Medicine is an online open-access journal that focuses on publishing peer-reviewed research in the field of digital medicine. The journal covers various aspects of digital medicine, including the application and implementation of digital and mobile technologies in clinical settings, virtual healthcare, and the use of artificial intelligence and informatics.
The primary goal of the journal is to support innovation and the advancement of healthcare through the integration of new digital and mobile technologies. When determining if a manuscript is suitable for publication, the journal considers four important criteria: novelty, clinical relevance, scientific rigor, and digital innovation.